IRIS Accounts Production v25.1.4.42 14345990 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh143459902023-12-31143459902024-12-31143459902024-01-012024-12-31143459902022-12-31143459902023-01-012023-12-31143459902023-12-3114345990ns15:EnglandWales2024-01-012024-12-3114345990ns14:PoundSterling2024-01-012024-12-3114345990ns10:Director12024-01-012024-12-3114345990ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3114345990ns10:SmallEntities2024-01-012024-12-3114345990ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3114345990ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3114345990ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3114345990ns10:FullAccounts2024-01-012024-12-3114345990ns10:OrdinaryShareClass12024-01-012024-12-3114345990ns10:Director22024-01-012024-12-3114345990ns10:RegisteredOffice2024-01-012024-12-3114345990ns5:CurrentFinancialInstruments2024-12-3114345990ns5:CurrentFinancialInstruments2023-12-3114345990ns5:Non-currentFinancialInstruments2024-12-3114345990ns5:Non-currentFinancialInstruments2023-12-3114345990ns5:ShareCapital2024-12-3114345990ns5:ShareCapital2023-12-3114345990ns5:SharePremium2024-12-3114345990ns5:SharePremium2023-12-3114345990ns5:RetainedEarningsAccumulatedLosses2024-12-3114345990ns5:RetainedEarningsAccumulatedLosses2023-12-3114345990ns5:LongLeaseholdAssetsns5:LandBuildings2024-01-012024-12-3114345990ns5:PlantMachinery2024-01-012024-12-3114345990ns5:FurnitureFittings2024-01-012024-12-3114345990ns5:ComputerEquipment2024-01-012024-12-3114345990ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-3114345990ns5:PlantMachinery2023-12-3114345990ns5:FurnitureFittings2023-12-3114345990ns5:ComputerEquipment2023-12-3114345990ns5:LongLeaseholdAssetsns5:LandBuildings2024-12-3114345990ns5:PlantMachinery2024-12-3114345990ns5:FurnitureFittings2024-12-3114345990ns5:ComputerEquipment2024-12-3114345990ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-3114345990ns5:PlantMachinery2023-12-3114345990ns5:FurnitureFittings2023-12-3114345990ns5:ComputerEquipment2023-12-3114345990ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3114345990ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3114345990ns5:CurrentFinancialInstruments2024-01-012024-12-3114345990ns5:Non-currentFinancialInstruments2024-01-012024-12-3114345990ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 14345990 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

LONDON LAURISTON CLINIC LTD

LONDON LAURISTON CLINIC LTD (REGISTERED NUMBER: 14345990)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


LONDON LAURISTON CLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: Svetlana Kopanja
James Emil Neffendorf





REGISTERED OFFICE: 34 Great Titchfield Street
London
United Kingdom
W1W 8BQ





REGISTERED NUMBER: 14345990 (England and Wales)





ACCOUNTANTS: MGR Weston Kay LLP
Chartered Accountants
55 Loudoun Road
St John's Wood
London
NW8 0DL

LONDON LAURISTON CLINIC LTD (REGISTERED NUMBER: 14345990)

BALANCE SHEET
31 DECEMBER 2024

31.12.24 31.12.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,138,443 512,965

CURRENT ASSETS
Debtors 5 280,838 309,646
Cash at bank 49,355 634,019
330,193 943,665
CREDITORS
Amounts falling due within one year 6 (549,826 ) (63,710 )
NET CURRENT (LIABILITIES)/ASSETS (219,633 ) 879,955
TOTAL ASSETS LESS CURRENT LIABILITIES 918,810 1,392,920

CREDITORS
Amounts falling due after more than one
year

7

(126,291

)

-
NET ASSETS 792,519 1,392,920

CAPITAL AND RESERVES
Called up share capital 8 1,151 1,096
Share premium 1,663,891 1,581,446
Retained earnings (872,523 ) (189,622 )
SHAREHOLDERS' FUNDS 792,519 1,392,920

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LONDON LAURISTON CLINIC LTD (REGISTERED NUMBER: 14345990)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 July 2025 and were signed on its behalf by:





Svetlana Kopanja - Director


LONDON LAURISTON CLINIC LTD (REGISTERED NUMBER: 14345990)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

London Lauriston Clinic limited is a private company limited by shares incorporated in England and Wales. The registered office is 34 Great Titchfield Street, London, United Kingdom, W1W 8BQ.

2. ACCOUNTING POLICIES

Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adapt the going concern basis of accounting in preparing the financial statements.

Reporting period
The financial statements cover a 12 month period to 31 December 2024, whereas the comparative figure relates to a 16 month period to 31 December 202. As a result, the figures are not directly comparable.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Leasehold Improvements - evenly over the period of the lease
Plant and machinery - 10% on cost
Fixtures and fittings - 20% on cost
Computer equipment - 33% on cost

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

LONDON LAURISTON CLINIC LTD (REGISTERED NUMBER: 14345990)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Hire purchase and leasing commitments
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2023 - 2 ) .

LONDON LAURISTON CLINIC LTD (REGISTERED NUMBER: 14345990)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


4. TANGIBLE FIXED ASSETS
Fixtures
Leasehold Plant and and Computer
Improvements machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 January 2024 442,767 112,192 5,262 1,187 561,408
Additions 487,249 216,544 36,710 26,109 766,612
At 31 December 2024 930,016 328,736 41,972 27,296 1,328,020
DEPRECIATION
At 1 January 2024 40,587 7,687 81 88 48,443
Charge for year 93,215 31,943 8,093 7,883 141,134
At 31 December 2024 133,802 39,630 8,174 7,971 189,577
NET BOOK VALUE
At 31 December 2024 796,214 289,106 33,798 19,325 1,138,443
At 31 December 2023 402,180 104,505 5,181 1,099 512,965

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade debtors 20,175 -
Other debtors 260,663 309,646
280,838 309,646

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Hire purchase contracts 47,731 -
Trade creditors 109,261 4,792
Taxation and social security 11,128 -
Other creditors 381,706 58,918
549,826 63,710

The lease purchase contracts are secured on the assets concerned.

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.12.24 31.12.23
£    £   
Hire purchase contracts 126,291 -

The lease purchase contracts are secured on the assets concerned.

LONDON LAURISTON CLINIC LTD (REGISTERED NUMBER: 14345990)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 31.12.23
value: £    £   
1,151 Ordinary £1 1,151 1,096

On 28 February 2024, the Company issued 55 ordinary shares at £1 per share with a premium of £1,499 per share.